ConductScience.org, home

Paper41753671

Serum Uric Acid-Reducing Effect and Intestinal Mucosal Barrier-Repairing Function of Limosilactobacillus reuteri MBHC10138.

Cheng J and 3 others. Microorganisms, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Serum Uric Acid-Reducing Effect and Intestinal Mucosal Barrier-Repairing Function of Limosilactobacillus reuteri MBHC10138. Papers, record 41753671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41753671

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum Uric Acid-Reducing Effect and Intestinal Mucosal Barrier-Repairing Function of Limosilactobacillus reuteri MBHC10138.
PubMed
Journal
Microorganisms
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
510170040617This research was funded by the Start-up Fund for Scientific Research of High-level Talents of Wuyi University.PubMed
No. RS-2023-00301938
This research was also supported by the Global - Learning & Academic research institution for Master's·PhD students, and Postdocs (LAMP) Program of the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education
PubMed
No. RS-2025-02663016by the Basic Science Research Program through the NRF funded by the Ministry of Education (No. RS-2025-02663016).PubMed
MBHC001This study was supported by R & D budget of MBHC Co. Ltd., Korea for development of functional probiotics and microbiome.PubMed

Source PubMed

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138674582Limosilactobacillus reuteri HCS02-001 Attenuates Hyperuricemia through Gut Microbiota-Dependent Regulation of Uric Acid Biosynthesis and Excretion.Microorganisms2024https://conductscience.org/library/papers/38674582PubMed
219725932Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?Arthritis Res Ther2009https://conductscience.org/library/papers/19725932PubMed
335334930Lactobacillus reuteri CCFM8631 Alleviates Hypercholesterolaemia Caused by the Paigen Atherogenic Diet by Regulating the Gut Microbiota.Nutrients2022https://conductscience.org/library/papers/35334930PubMed
426852926Intestinal Microbiota Distinguish Gout Patients from Healthy Humans.Sci Rep2016https://conductscience.org/library/papers/26852926PubMed
526863122PROGNOSTIC VALUE OF PLASMA TIGHT-JUNCTION PROTEINS FOR SEPSIS IN EMERGENCY DEPARTMENT: AN OBSERVATIONAL STUDY.Shock2016https://conductscience.org/library/papers/26863122PubMed
630843748Molecular mechanistic insight into the anti-hyperuricemic effect of Eucommia ulmoides in mice and rats.Pharm Biol2019https://conductscience.org/library/papers/30843748PubMed
819565556Hyperuricemia and risk of stroke: a systematic review and meta-analysis.Arthritis Rheum2009https://conductscience.org/library/papers/19565556PubMed
918636784A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?Drug Saf2008https://conductscience.org/library/papers/18636784PubMed
1019337060A prospective study of gout and cancer.Eur J Cancer Prev2009https://conductscience.org/library/papers/19337060PubMed
1132452918The role of uric acid in inflammasome-mediated kidney injury.Curr Opin Nephrol Hypertens2020https://conductscience.org/library/papers/32452918PubMed
1235438552Probiotic Characterization of Lactobacillus brevis MJM60390 and In Vivo Assessment of Its Antihyperuricemic Activity.J Med Food2022https://conductscience.org/library/papers/35438552PubMed
1323981744HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.Int J Rheum Dis2013https://conductscience.org/library/papers/23981744PubMed
1439600720Lactobacillus paracasei 259 alleviates hyperuricemia in rats by decreasing uric acid and modulating the gut microbiota.Front Nutr2024https://conductscience.org/library/papers/39600720PubMed
1515743917HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15743917PubMed
1634478742The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.Gastroenterology2021https://conductscience.org/library/papers/34478742PubMed
1728028921Oscillospira and related bacteria - From metagenomic species to metabolic features.Environ Microbiol2017https://conductscience.org/library/papers/28028921PubMed
1832219059Verification with the utility of an established rapid assessment of brain safety for newly developed vaccines.Lab Anim Res2019https://conductscience.org/library/papers/32219059PubMed
1931056705URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers.Rheumatology (Oxford)2019https://conductscience.org/library/papers/31056705PubMed
2033764849Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid.Gut Microbes2021https://conductscience.org/library/papers/33764849PubMed
2132271169Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.JCI Insight2020https://conductscience.org/library/papers/32271169PubMed

See all 68 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42650279Blue Honeysuckle Extract Ameliorates Hyperuricemia by Modulating Gut Microbiota and Improving Liver-Kidney-Gut Axis Function.Antioxidants (Basel)2026https://conductscience.org/library/papers/42650279

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
OCLN100506658PubTator's text mininghttps://conductscience.org/library/genes/100506658

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41753671

GET https://conductscience.org/api/papers/v1/41753671/references?page=2